Ignite Creation Date:
2024-05-05 @ 4:57 PM
Last Modification Date:
2024-10-26 @ 9:26 AM
Study NCT ID:
NCT00354770
Status:
COMPLETED
Last Update Posted:
2023-02-23
First Post:
2006-07-18
Brief Title:
N-Acetyl Cysteine in Trichotillomania
Sponsor:
University of Chicago
Organization:
University of Chicago
Study Overview
Official Title:
A Double-Blind Placebo-Controlled Study of N-Acetyl Cysteine in Trichotillomania
Status:
COMPLETED
Status Verified Date:
2023-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a 12-week double-blind study of N-Acetyl Cysteine in the treatment of trichotillomania
Detailed Description:
The goal of the proposed study is to evaluate the efficacy and safety of N-Acetyl Cysteine NAC in trichotillomania Forty subjects with DSM-IV trichotillomania will receive 12 weeks of double-blind NAC or placebo The hypothesis to be tested is that NAC will be effective and well tolerated in patients with trichotillomania compared to placebo The proposed study will provide needed data on the treatment of a disabling disorder that currently lacks a clearly effective treatment
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None